9 results found.

Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer, or Clinical Trial using cabozantinib-s-malate; sunitinib malate; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Randomized Phase II Study Comparing Cabozantinib With Commercially Supplied Sunitinib in Patients With Previously Untreated Locally Advanced or Metastatic Renal Cell Carcinoma.
cabozantinib-s-malate; sunitinib malate; laboratory biomarker analysis

Clear Cell Renal Cell Carcinoma, or Stage IV Renal Cell Cancer Clinical Trial using entinostat; aldesleukin; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18; positron emission tomography; computed tomography

National Cancer Institute (NCI) - Recruiting 18 years or older.
- Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination With the Histone Deacetylase Inhibitor Entinostat in Patients With Metastatic Renal Cell Carcinoma.
entinostat; aldesleukin; pharmacological study; laboratory biomarker analysis; fludeoxyglucose F 18; positron emission tomography; computed tomography

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Sta Clinical Trial using bevacizumab; anti-endoglin monoclonal antibody TRC105; laboratory biomarker analysis; pharmacological study

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Phase II Study of Bevacizumab Alone or in Combination With TRC 105 for Advanced Renal Cell Cancer.
bevacizumab; anti-endoglin monoclonal antibody TRC105; laboratory biomarker analysis; pharmacological study

Clear Cell Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage Clinical Trial using pazopanib hydrochloride; therapeutic conventional surgery

Case Comprehensive Cancer Center - Recruiting 18 years or older.
- A Phase II Study of Pazopanib to Enable Partial Nephrectomy.
pazopanib hydrochloride; therapeutic conventional surgery

Kidney Cancer Clinical Trial using motexafin gadolinium; sunitinib malate; comparative genomic hybridization; gene expression analysis; mutation analysis; polymorphism analysis; immunohistochemistry staining method; iodine I-124 girentuximab; laboratory biomarker analysis; pharmacological study; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Histopathologic and Imaging Study of Renal Cell Carcinoma Vasculature in the Setting of Sunitinib Therapy Prior to Cytoreductive Nephrectomy.
motexafin gadolinium; sunitinib malate; comparative genomic hybridization; gene expression analysis; mutation analysis; polymorphism analysis; immunohistochemistry staining method; iodine I-124 girentuximab; laboratory biomarker analysis; pharmacological study; adjuvant therapy; neoadjuvant therapy; therapeutic conventional surgery

Recurrent Renal Cell Cancer, Stage I Renal Cell Cancer, or Stage Clinical Trial using fluorescence imaging; laparoscopic surgery; indocyanine green

City of Hope Medical Center - Recruiting 18 years or older.
- A Prospective Investigation of the Use of the Fluorescence Imaging on the da Vinci Surgical System for Intraoperative Near Infrared Imaging of Renal Cortical Tumors.
fluorescence imaging; laparoscopic surgery; indocyanine green

Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Sta Clinical Trial using ziv-aflibercept; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 18 years or older.
- A Randomized Phase II Study to Determine the Effect of 2 Different Doses AVE0005 (VEGF Trap) in Patients With Metastatic Renal Cell Carcinoma.
ziv-aflibercept; laboratory biomarker analysis

Recurrent Renal Cell Cancer, or Stage IV Renal Cell Cancer Clinical Trial using stereotactic body radiation therapy; therapeutic conventional surgery; laboratory biomarker analysis

Roswell Park Cancer Institute - Recruiting 18 years or older.
- Immunologic Impact of Stereotactic Body Radiation Therapy (SBRT) in Renal Cell Carcinoma.
stereotactic body radiation therapy; therapeutic conventional surgery; laboratory biomarker analysis

Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma Clinical Trial using laboratory biomarker analysis; cytology specimen collection procedure

Children's Oncology Group - Recruiting N/A to 29 years.
- Renal Tumors Classification, Biology, and Banking Study.
laboratory biomarker analysis; cytology specimen collection procedure